Bile Acid Profiling Using UltraPerformance Convergence Chromatography (UPC2) Coupled to ESI-MS/MS

Importance of the topic

Bile acids act as key regulators of lipid, cholesterol and glucose metabolism and serve as clinical biomarkers of liver and metabolic diseases. Rapid and comprehensive profiling of these molecules supports drug discovery and diagnostic research by providing detailed insights into metabolic pathways and disease states.

Objectives and study overview

The primary goal of this study was to develop a novel, high-throughput method for simultaneous separation and quantification of 25 bile acids, including glycine and taurine conjugates, using UltraPerformance Convergence Chromatography (UPC2) coupled with ESI-MS/MS. The target was to achieve complete profiling within 13 minutes, doubling the speed of conventional LC approaches.

Methodology and instrumentation

A Waters ACQUITY UPC2 system using supercritical CO₂ as the main mobile phase enabled fast analyte diffusion and low back pressure. A sub-2-µm particle column was optimized for temperature, stationary phase selection, modifier pH and additive concentration. Detection was performed on a Xevo TQ-S mass spectrometer operating in negative ESI mode without make-up flow to maximize sensitivity. Sample preparation for rat serum involved protein precipitation with methanol (3:1 v/v), vortex mixing, centrifugation and direct injection of the supernatant.

Main results and discussion

Complete chromatographic separation of all 25 bile acids was achieved in 13 minutes, representing a two-fold improvement over traditional LC methods. The optimized UPC2 conditions delivered acceptable resolution for isomeric and conjugated forms. Quantitative analysis in rat serum demonstrated excellent reproducibility (n=6) and sensitivity in the low pg/µL range, enabling precise determination of individual bile acid concentrations in biological fluids.

Benefits and practical applications

• High-throughput profiling of bile acids for metabolic and clinical research
• Improved resolution of isomeric and conjugated species without derivatization
• Streamlined sample preparation and rapid turnaround for routine analysis
• Enhanced sensitivity and specificity for biomarker discovery and drug development

Future trends and potential applications

Advances in convergence chromatography and mass spectrometry are expected to expand the range of detectable metabolites, enabling simultaneous profiling of sterols, lipids and other small molecules. Integration with high-resolution MS, automated sample handling and data processing workflows will further increase throughput and robustness, paving the way for clinical implementation and large cohort studies.

Conclusion

The UPC2-ESI-MS/MS method described provides a rapid, sensitive and reliable platform for comprehensive bile acid profiling in under 13 minutes. Its high throughput and minimal sample preparation make it well suited for research applications in metabolic disease, biomarker discovery and pharmaceutical development.

Reference

1. Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. The EMBO Journal. 2006;25(7):1419–1425.
2. Barnes S, Gallo GA, Trash DB, Morris JS. Diagnostic value of serum bile acid estimations in liver disease. Journal of Clinical Pathology. 1975;28(6):506–509.
3. Qiao X et al. Metabolic regulatory effects of licorice: a bile acid metabonomic study by LC-MS/MS. Steroids. 2012;77(7):745–755.
4. Patti ME et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity. 2009;17(9):1671–1677.
5. Ye L et al. HPLC-MS/MS for analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy. Journal of Chromatography B. 2007;860(1):10–17.